BlackRock Fund Advisors’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
$22K Buy
5,277
+1,061
+25% +$4.42K ﹤0.01% 3875
2016
Q3
$16K Sell
4,216
-3,790
-47% -$14.4K ﹤0.01% 3905
2016
Q2
$27K Sell
8,006
-596,356
-99% -$2.01M ﹤0.01% 3885
2016
Q1
$3.21M Buy
604,362
+27,753
+5% +$147K ﹤0.01% 2938
2015
Q4
$7.09M Buy
576,609
+147,586
+34% +$1.82M ﹤0.01% 2649
2015
Q3
$6.26M Buy
429,023
+5,029
+1% +$73.4K ﹤0.01% 2667
2015
Q2
$8.27M Buy
423,994
+4,224
+1% +$82.4K ﹤0.01% 2616
2015
Q1
$7.6M Buy
419,770
+3,376
+0.8% +$61.1K ﹤0.01% 2601
2014
Q4
$9.83M Buy
416,394
+91,123
+28% +$2.15M ﹤0.01% 2469
2014
Q3
$7.87M Sell
325,271
-10,288
-3% -$249K ﹤0.01% 2493
2014
Q2
$9.43M Sell
335,559
-26,044
-7% -$732K ﹤0.01% 2457
2014
Q1
$12.3M Buy
361,603
+13,517
+4% +$460K ﹤0.01% 2280
2013
Q4
$6.65M Buy
348,086
+30,549
+10% +$583K ﹤0.01% 2635
2013
Q3
$5.15M Buy
317,537
+36,810
+13% +$597K ﹤0.01% 2798
2013
Q2
$2.95M Buy
+280,727
New +$2.95M ﹤0.01% 2998